Net earnings attributable to Clorox fell 27.5% to $587.0M, as net sales declined 5.4% to $6.72B, which the company attributes to lower shipments in the current period following the incremental shipments related to the ERP transition in the fourth quarter of fiscal year 2025, partially offset by the benefit of the GOJO acquisition.

Filed August 7, 2026 · Period ending June 30, 2026 · Compared to 10-K Aug 8, 2025 · ~1 min read

Key Changes

• high

  Net sales decreased 5.4% to $6.72B, which the company attributes to lower shipments in the current period following the incremental shipments related to the ERP transition in the fourth quarter of fiscal year 2025, partially offset by the benefit of the GOJO acquisition.

  view on EDGAR →
• high

  Gross margin declined 2.9 percentage points to 42.3%, which the company attributes to lower net sales and higher manufacturing and logistics costs, partially offset by cost savings.

  view on EDGAR →
• high

  Diluted EPS fell 26.2% to $4.81, which the company attributes to lower net sales and higher manufacturing and logistics costs, partially offset by lapping losses on the divestiture of the Better Health VMS business in the prior period and cost savings in the current period.

  view on EDGAR →